SCHEMBL20148607

SCHEMBL20148607

CC(C)N1CC2CC(C1)N2C(=O)C1CCC1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
RECQL P46063 1/20 0.44
CHRNB2 P17787 2/20 0.40
CHRNA3 P32297 2/20 0.40
CHRNA4 P43681 2/20 0.40
CHRNB3 Q05901 2/20 0.40
CHRNA6 Q15825 2/20 0.40
HRH3 Q9Y5N1 2/20 0.38
GAA P10253 1/20 0.38
CNR1 P21554 1/20 0.38
CCR2 P41597 4/20 0.37
TSHR P16473 2/20 0.37
PIK3CD O00329 1/20 0.35
HSD11B1 P28845 5/20 0.34
CYP2D6 P10635 1/20 0.33
ALDH1A1 P00352 1/20 0.33
GRM5 P41594 1/20 0.33
HSD11B2 P80365 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20071310 0.97 RECQL (0.44) RECQLCHRNB2CHRNA3CHRNA4CHRNB3
SCHEMBL20148605 0.95 RECQL (0.47) RECQLCHRNB2CHRNA3CHRNA4CHRNB3
SCHEMBL20071302 0.93 HRH3 (0.40) RECQLCHRNB2CHRNA3CHRNA4CHRNB3
SCHEMBL20071315 0.88 PIK3CD (0.40) RECQLCHRNB2CHRNA3CHRNA4CHRNB3
SCHEMBL26203668 0.88 RECQL (0.46) RECQLCHRNB2CHRNA3CHRNA4CHRNB3
SCHEMBL20148606 0.87 MAPT (0.38) RECQLCHRNB2CHRNA3CHRNA4CHRNB3
SCHEMBL20070420 0.87 PIK3CD (0.49) HRH3CCR2TSHRPIK3CD
SCHEMBL21738123 0.85 HRH3 (0.41) RECQLHRH3CNR1PIK3CDALDH1A1
SCHEMBL24767230 0.84 HRH3 (0.33) HRH3CNR1
SCHEMBL20154458 0.84 RECQL (0.36) RECQLCHRNB2CHRNA3CHRNA4CHRNB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240066029-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS ARRAY BIOPHARMA INC. 2024-02-29 US disclosed
US-20180133200-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS ARRAY BIOPHARMA INC. 2018-05-17 US disclosed
US-20180133200-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS ARRAY BIOPHARMA INC. 2018-05-17 US disclosed
US-20180133213-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS ARRAY BIOPHARMA INC. 2018-05-17 US disclosed
US-20180134702-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS ARRAY BIOPHARMA INC. 2018-05-17 US disclosed
US-20180134702-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS ARRAY BIOPHARMA INC. 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180134702-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS RET, ROR1, BRAF RECQL 835/4885CHRNB2 2276/4885CHRNA3 1700/4885
US-20180133200-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS RET, ROR1, BRAF RECQL 835/4885CHRNB2 2276/4885CHRNA3 1700/4885
US-20180133213-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS RET, ROR1, BRAF RECQL 835/4885CHRNB2 2276/4885CHRNA3 1700/4885
US-20240066029-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS RET, ROR1, BRAF RECQL 835/4885CHRNB2 2276/4885CHRNA3 1700/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.